- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT02770833
Acute Effects of Different Protein Sources and Different Glycemic Index on Energy Balance, Glucose Allostasis and Amino Acid Metabolism: a Randomized, 4-condition, Two Cross-over Study in Adults. (FINS)
Acute Effects of Different Protein Sources and Different Glycemic Index on Energy Balance, Glucose Allostasis and Amino Acid Metabolism.
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Tipo di studio
Iscrizione (Effettivo)
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
Frederiksberg
-
Copenhagen, Frederiksberg, Danimarca, 1958
- Department of Nutrition, Exercise and Sports
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- Healthy men and women
- Between 18 and 50 years of age
- BMI between 25.0 and 30.0 kg×m-2
- Fasting blood glucose < 5.9 mmol/L (measured at the screenings visit)
- Non-smoker
Exclusion Criteria:
- Self-reported eating disorders or irregular eating schedule (e.g. skipping breakfast)
- Chronic diseases (e.g. cancer, asthma, back pain, thyroid disease, heart disease, diabetes, neurological disorders, or sleep disorders)
- Use currently or within the previous 3 months of prescription medication that has the potential of affecting body weight or glucose metabolism such as glucocorticoids (but excluding inhaled and topical steroids; bronchodilators are allowed), psychoactive medication, epileptic medication, or weight loss medications (either prescription, over the counter or herbal). Low dose antidepressants are allowed if they, in the judgement of the investigator, do not affect weight or participation to the study protocol. Levothyroxine for treatment of hypothyroidism is allowed if the participant has been on a stable dose for at least 3 months.
- Women who are pregnant, breast-feeding or have intention of becoming pregnant during the study period
- Menopausal women and women with an irregular menstrual cycle
- Food allergies
- Substance abuse
- Vigorous physical activity more than 10 hours/week
- Alcohol intake above the recommendations from the Danish Health and Medicines Authority
- Caffeine intake above 300 mg/day
- Night- or shift work
- Blood donation <1 month before study commencement and during study period
- Simultaneous participation in other clinical studies
- Inability, physically or mentally, to comply with the procedures required by the study protocol, as evaluated by the study staff
- Subject's general condition contraindicates continuing the study, as judged by the study personnel or the medical expert
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Prevenzione
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione incrociata
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: Salmon vs. veal and CHO with low or high GI
In the first clinical study (Study 1), subjects will eat salmon or veal combined with high or low GI carbohydrates. Each subject will be engaged in each of the following four 1-day test meals:
|
|
|
Sperimentale: Cod vs. veal and CHO with low or high GI
In the second clinical study (Study 2), subjects will eat codfish or veal combined with high or low GI carbohydrates. Each subject will be engaged in each of the following four 1-day test meals:
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Differences in diet induced thermogenesis between the four test meals
Lasso di tempo: 3 hours
|
In the following three hours after eating the test meal respiratory gas exchange will be measured 6x25 minutes with 5 minutes breaks in between each measurement.
Diet induced thermogenesis (DIT) will be measured by indirect calorimetry using a ventilated hood system.
Each measurement will last for 25 minutes of which the last 20 minutes will be used for calculation of energy expenditure.
|
3 hours
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Satiety
Lasso di tempo: 3 hours
|
Evaluated by VAS-measures of subjective appetite sensations (satiety, hunger, fullness and prospective food consumption)
|
3 hours
|
|
Food preferences
Lasso di tempo: 3 hours
|
In an attempt to measure spontaneous energy intake and macronutrient preferences in an experimental context, the participants will be given an ad libitum buffet lunch at noon.
A cold and hot buffet-style lunch comprising a variety of foods (representing a wide selection of food groups) will be offered after the last measurement of gas exchange and the participants will be instructed to eat ad libitum.
|
3 hours
|
|
Glucose
Lasso di tempo: 3 hours
|
Blood sample
|
3 hours
|
|
Insulin
Lasso di tempo: 3 hours
|
Blood sample
|
3 hours
|
|
Glucagon
Lasso di tempo: 3 hours
|
Blood sample
|
3 hours
|
|
C-peptide
Lasso di tempo: 3 hours
|
Blood sample
|
3 hours
|
|
Plasma amino acids
Lasso di tempo: 3 hours
|
Blood samples
|
3 hours
|
|
Appetite regulating hormones
Lasso di tempo: 3 hours
|
e.g.
glucagon-like peptide-1 (GLP-1)
|
3 hours
|
|
Free fatty acids
Lasso di tempo: 3 hours
|
Blood sample
|
3 hours
|
|
Glycerol
Lasso di tempo: 3 hours
|
Blood sample
|
3 hours
|
Collaboratori e investigatori
Sponsor
Collaboratori
Investigatori
- Investigatore principale: Anne Raben, Prof, Prof at the department of Nutrition, Exercise and Sports
Studiare le date dei record
Studia le date principali
Inizio studio
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Stima)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Stima)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- H-1-2014-038 (B314)
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .